SightfileU.S. market data from official filings

IN8BIO INC (INAB)

Name: IN8BIO INC (INAB) — Institutional ownership, SEC filings and insider activity
Creator: Sightfile
License: https://www.sec.gov/privacy#dissemination

Institutional ownership, SEC filings and insider activity

Sector: Healthcare & Pharma · SEC CIK 0001740279 · EDGAR filings · Updated 2026-06-01

IN8BIO INC (INAB) has reported institutional ownership of 38.1%, with 19 institutional managers holding positions valued at $5.55M per the latest 13F reporting period. SEC filings include an active notice of delisting or failure to satisfy a continued listing rule (8-K Item 3.01), substantial-doubt (going concern) disclosure per the filings.

Institutional ownership

38.1%

Institutional managers

Reported 13F value

$5.55M

Insider activity

12 trans.

$0 net flat

Data flags

2 active

from SEC filings

Latest updates

2026-06-01 — Current report (8-K) filed
2026-06-01 — Prospectus supplement (424B5) filed
2026-05-29 — SCHEDULE 13D/A filed
2026-05-29 — Insider transaction reported (Form 4)
2026-05-19 — EFFECT filed
2026-05-18 — S-3/A filed

Institutional ownership overview

According to SEC 13F filings tracked by Sightfile, IN8BIO INC has 19 institutional holders and institutional ownership of 38.1%.

Insider activity

Insiders reported 12 transactions (0 buys, 0 sells) across 8 reporting insiders, with a net reported value of $0.

Data flags from SEC filings

Active substantial-doubt (going concern) disclosure per the filings, most recently filed 2026-05-07 (recurring since 2022-11-10) — source filing. The authoritative details are those stated in the filing itself.

Active notice of delisting or failure to satisfy a continued listing rule (8-K Item 3.01), most recently filed 2025-02-07 (recurring since 2024-08-08) — source filing. The authoritative details are those stated in the filing itself.

Related companies

Scilex Holding Co (SCLX) · Natural Alternatives International Inc (NAII) · Vivani Medical Inc (VANI) · ESTRELLA IMMUNOPHARMA INC (ESLA) · ACTINIUM PHARMACEUTICALS INC (ATNM) · Lisata Therapeutics Inc (LSTA)

See full history, cross-references and alerts on Sightfile

Sightfile provides information only — not investment advice, recommendations, or an assessment of any security. Data is derived from official public sources (SEC EDGAR and U.S. government agencies), may contain errors or delays, and should be verified against the source filing before relying on it.
Data sources: SEC EDGAR (filings, 13F, FTD), aggregated by Sightfile. Page updated 2026-06-01.